Event Details

Verastem Research and Development Day and discussion of acquisition of Clinical-Stage FAK Inhibitor from Pfizer

Jul 12, 2012 at 9:00 AM EDT

Webcast Presentation

Live Teleconference Information

Primary # -
Secondary # -
Passcode -
73322380
Title
Verastem Research and Development Day and discussion of acquisition of Clinical-Stage FAK Inhibitor from Pfizer
Date / Time
Jul 12, 2012 at 9:00 AM EDT

Investor Contact

getty
John Doyle

VP Investor Relations & Finance
781.292.4279
jdoyle@verastem.com

Joe Rayne

Argot Partners
617.340.6075
joseph@argotpartners.com